Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus

Abstract

The Framingham risk score is widely used to identify patients at increased cardiovascular risk, and women with systemic lupus erythematosus (SLE) have a marked increased prevalence of cardiovascular events. Thus, we examined the hypothesis that cardiovascular risk scores would identify women with SLE who had asymptomatic coronary atherosclerosis. Ninety-three women with SLE and 65 control subjects were studied. The Framingham score and a score for younger populations developed from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study were compared in both groups. Coronary atherosclerosis was ascertained by electron beam computed tomography. There were no significant differences in the median (interquartile range) Framingham [5 (2-10) compared to 7 (0-10), P = 0.88] and PDAY [15 (14-18) compared to 16 (13-18), P = 0.99] scores in patients with SLE and controls, respectively. Coronary atherosclerosis was associated with higher Framingham [12 (3-15) compared to 4 (1-8), P = 0.008] and PDAY [17 (15-19 compared to 15 (12-18), P = 0.03)] scores in patients with SLE; however, 99% of patients were classified as low-risk with a 10-year predicted risk of 1% (<1-3%). Our data indicate that cardiovascular risk scores are not adequate for risk stratification in women with SLE. Measurement of coronary calcification may add information to identify asymptomatic women with lupus who might benefit from aggressive preventive measures.

Keywords

cardiovascular risk scores EBCT Framingham systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Manzi S , Meilahn EN , Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study . Am J Epidemiol 1997; 145: 408-415 .

Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus . Arthritis Rheum 1999; 42: 338-346 .

Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort . Lupus 2000; 9: 170-175 .

Manzi S , Selzer F , Sutton-Tyrrell K et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus . Arthritis Rheum 1999; 42: 51-60 .

Bruce IN , Urowitz MB , Gladman DD , Ibanez D , Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study . Arthritis Rheum 2003; 48: 3159-3167 .

Ford ES , Giles WH , Mokdad AH. The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III . J Am Coll Cardiol 2004; 43: 1791-1796 .

Wilson PW , D’Agostino RB , Levy D , Belanger AM , Silbershatz H , Kannel WB. Prediction of coronary heart disease using risk factor categories . Circulation 1998; 97: 1837-1847 .

Gidding SS , McMahan CA , Mcgill HC et al. PDAY risk score predicts coronary artery calcium in young adults: The CARDIA study . Circulation 2004; 110: 790-790 .

McMahan CA , Gidding SS , Fayad ZA et al. Risk scores predict athero-sclerotic lesions in young people . Arch Intern Med 2005; 165: 883-890 .

10.

Schisterman EF , Whitcomb BW. Coronary age as a risk factor in the modified Framingham risk score . BMC Med Imaging 2004; 4: 1-1 .

11.

Michos ED , Vasamreddy CR , Becker DM et al. Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis . Am Heart J 2005; 150: 1276-1281 .

12.

Michos ED , Nasir K , Braunstein JB et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women . Atherosclerosis 2006; 184: 201-206 .

13.

Nasir K , Michos ED , Blumenthal RS , Raggi P. Detection of high-risk young adults and women by coronary calcium and national cholesterol education program panel III guidelines . J Am Coll Cardiol 2005; 46: 1931-1936 .

14.

Shaw LJ , Raggi P , Schisterman E , Berman DS , Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality . Radiology 2003; 228: 826-833 .

15.

Achenbach S , Nomayo A , Couturier G et al. Relation between coronary calcium and 10-year risk scores in primary prevention patients . Am J Cardiol 2003; 92: 1471-1475 .

16.

Greenland P , LaBree L , Azen SP , Doherty TM , Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals . JAMA 2004; 291: 210-215 .

17.

Asanuma Y , Oeser A , Shintani AK et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus . N Eng J Med 2003; 349: 2407-2415 .

18.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1277 .

19.

Third Report of the National Cholesterol Education Program (NCEP) . Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report . Circulation 2002; 106: 3143-3421 .

20.

Oeser A , Chung CP , Asanuma Y , Avalos I , Stein CM. Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus . Arthritis Rheum 2005; 52: 3651-3659 .

21.

Asanuma Y , Chung CP , Oeser A et al. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors . J Rheumatol 2006; 33: 539-545 .

22.

Turner E , Dishy V , Chung CP et al. Endothelial function in systemic lupus erythematosus: relationship to disease activity, cardiovascular risk factors, corticosteroid therapy and coronary calcification . Vascular Health and Risk Management 2005; 1: 357-360 .

23.

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) . Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) . JAMA 2001; 285: 2486-2497 .

24.

Bombardier C , Gladman DD , Urowitz MB , Caron D , Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE . Arthritis Rheum 1992; 35: 630-640 .

25.

Gladman D , Ginzler E , Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus . Arthritis Rheum 1996; 39: 363-369 .

26.

Agatston AS , Janowitz WR , Hildner FJ , Zusmer NR , Vaimonte M Jr , Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography . J Am Coll Cardiol 1990; 15: 827-832 .

27.

Hecht HS , Superko HR. Electron beam tomography and national cholesterol education program guidelines in asymptomatic women . J Am Coll Cardiol 2001; 37: 1506-1511 .

28.

Akosah KO , Schaper A , Cogbill C , Schoenfeld P.

Preventing myocardial infarction in the young adult in the first place: how do the national cholesterol education panel III guidelines perform?

J Am Coll Cardiol 2003; 41: 1475-1479 .

29.

Bessant R , Hingorani A , Patel L , MacGregor A , Isenberg DA , Rahman A. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus . Rheumatology (Oxford) 2004; 43: 924-929 .

30.

Esdaile JM , Abrahamowicz M , Grodzicky T et al. Traditional Framing-ham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus . Arthritis Rheum 2001; 44: 2331-2337 .

31.

Raggi P , Cooil B , Callister TQ. Use of electron beam tomography data to develop models for prediction of hard coronary events . Am Heart J 2001; 141: 375-382 .

32.

Kondos GT , Hoff JA , Sevrukov A et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low-to intermediate-risk adults . Circulation 2003; 107: 2571-2576 .

33.

Raggi P , Cooil B , Shaw LJ et al. Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction . Am J Cardiol 2003; 92: 827-829 .

34.

Pletcher M , Tice J , Pignone M , McCulloch C , Callister T , Browner W. What does my patient’s coronary artery calcium score mean? Combining information from the coronary artery calcium score with information from conventional risk factors to estimate coronary heart disease risk . BMC Med 2004; 2: 31-31 .

35.

Becker CR , Majeed A , Crispin A et al. CT measurement of coronary calcium mass: impact on global cardiac risk assessment . Eur Radiol 2005; 15: 96-101 .

36.

Bruce IN.

Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?

Best Pract Res Clin Rheumatol 2005; 19: 823-838 .

37.

Wanner C , Krane V , Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis . N Engl J Med 2005; 353: 238-248 .